{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:05:49Z","timestamp":1770217549588,"version":"3.49.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[1999,4,1]],"date-time":"1999-04-01T00:00:00Z","timestamp":922924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[1999,4]]},"DOI":"10.1016\/s0169-409x(98)00082-9","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T02:54:20Z","timestamp":1027652060000},"page":"145-163","source":"Crossref","is-referenced-by-count":63,"title":["Blood\u2013brain barrier permeability to small and large molecules"],"prefix":"10.1016","volume":"36","author":[{"given":"Eain M.","family":"Cornford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyo","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0169-409X(98)00082-9_BIB1","first-page":"787","article-title":"Epilepsy and the blood\u2013brain barrier","volume":"44","author":"Cornford","year":"1986","journal-title":"Adv. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/ana.410010502","article-title":"The large apparent work capability of the blood\u2013brain barrier: a study of mitochondrial content of capillary endothelial cells in brain and other tissues of the rat","volume":"1","author":"Oldendorf","year":"1977","journal-title":"Ann. Neurol."},{"issue":"Suppl. 2","key":"10.1016\/S0169-409X(98)00082-9_BIB3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1212\/WNL.28.9_Part_2.84","article-title":"The capillaries in acute and subacute multiple sclerosis plaques: a morphometric analysis","volume":"28","author":"Brown","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0026-2862(87)90022-7","article-title":"A quantitative analysis of blood\u2013brain barrier ultrastructure in the aging human","volume":"33","author":"Stewart","year":"1987","journal-title":"Microvasc. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/jemt.1070270606","article-title":"Quantitation of blood\u2013brain barrier ultrastructure","volume":"27","author":"Stewart","year":"1994","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-0173(91)90020-9","article-title":"Drug metabolizing enzymes in the brain and cerebral microvessels","volume":"16","author":"Minn","year":"1991","journal-title":"Brain Res. Rev."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/1357-4310(96)88720-X","article-title":"Transporting therapeutics across the blood\u2013brain barrier","volume":"2","author":"Abbott","year":"1996","journal-title":"Mol. Med. Today"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","article-title":"Biochemistry of multidrug resistance mediated by the multidrug transporter","volume":"62","author":"Gottesman","year":"1993","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB9","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1046\/j.1471-4159.1997.68031278.x","article-title":"Brain microvascular and astrocyte localization of P-glycoprotein","volume":"68","author":"Pardridge","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB10","unstructured":"W.M. Pardridge, Peptide Drug Delivery to the Brain, Raven Press, New York, 1991."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB11","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1073\/pnas.86.12.4761","article-title":"Blood\u2013brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein","volume":"86","author":"Triguero","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0006-291X(87)90726-1","article-title":"Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood\u2013brain barrier","volume":"146","author":"Pardridge","year":"1987","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB13","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1016\/S0021-9258(18)48160-4","article-title":"Absorptive-mediated endocytosis of cationized albumin and a \u03b2-endorphin-cationized albumin chimeric peptide by isolated brain capillaries","volume":"262","author":"Kumagai","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB14","first-page":"893","article-title":"Evaluation of cationized rat albumin as a potential blood\u2013brain barrier drug transport vector","volume":"255","author":"Pardridge","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1210\/endo-126-2-977","article-title":"\u03b2-Endorphin chimeric peptides: transport through the blood\u2013brain barrier in vivo and cleavage of disulfide linkage by brain","volume":"126","author":"Pardridge","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB16","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1023\/A:1018942728317","article-title":"Insulin fragments as a carrier for peptide delivery across the blood\u2013brain barrier","volume":"11","author":"Fukuta","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB17","first-page":"448","article-title":"NGF and anti-transferrin receptor antibody conjugate: short and long term effects on survival of cholinergic neurons in intraocular septal transplants","volume":"268","author":"Granholm","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB18","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1073\/pnas.90.7.2618","article-title":"Pharmacologic effects in vivo in brain by vector-mediated peptide drug delivery","volume":"90","author":"Bickel","year":"1993","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1018940732550","article-title":"Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood\u2013brain barrier in vivo using vector-mediated peptide drug delivery","volume":"11","author":"Pardridge","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB20","first-page":"77","article-title":"CNS pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analogue coupled to a blood\u2013brain barrier drug delivery system","volume":"279","author":"Wu","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB21","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1023\/A:1018982125649","article-title":"Brain delivery of biotin bound to a conjugate of neutral avidin and cationized human albumin","volume":"11","author":"Kang","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB22","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI119708","article-title":"Drug targeting of a peptide radiopharmaceutical through the primate blood\u2013brain barrier in vivo with a monoclonal antibody to the human insulin receptor","volume":"100","author":"Wu","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/bc970027g","article-title":"Peptide targeting and delivery across the blood\u2013brain barrier utilizing synthetic triglyceride esters: design, synthesis, and bioactivity","volume":"8","author":"Patel","year":"1996","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/bc00029a005","article-title":"Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide\u2013avidin conjugates","volume":"5","author":"Boado","year":"1994","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB25","first-page":"206","article-title":"Pharmacokinetics of blood\u2013brain barrier transport of [3H]-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system","volume":"276","author":"Wu","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB26","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1073\/pnas.92.12.5592","article-title":"Vector mediated delivery of a peptide nucleic acid through the blood\u2013brain barrier in vivo","volume":"92","author":"Pardridge","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/S0169-409X(98)00082-9_BIB27","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1073\/pnas.92.7.2820","article-title":"Transferrin-antibody fusion proteins are effective in brain targeting","volume":"92","author":"Shin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB28","doi-asserted-by":"crossref","first-page":"14164","DOI":"10.1073\/pnas.93.24.14164","article-title":"Brain drug delivery of small molecules using immunoliposomes","volume":"93","author":"Huwyler","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB29","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1089\/hum.1996.7.17-2135","article-title":"Central nervous system delivery of recombinant ciliary neurotrophic factor by polymer encapsulated differentiated C2C12 myoblasts","volume":"7","author":"Deglon","year":"1996","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB30","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0167-7799(97)01095-0","article-title":"Drug delivery to the nervous system","volume":"15","author":"Maysinger","year":"1997","journal-title":"Trends Biotechnol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1227\/00006123-198610000-00011","article-title":"Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood brain barrier modification in glioblastoma","volume":"19","author":"Neuwelt","year":"1986","journal-title":"Neurosurgery"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB32","doi-asserted-by":"crossref","unstructured":"E.A. Neuwelt, S.A. Dahlborg, Blood\u2013brain barrier disruption in the treatment of brain tumors: clinical implications, in: E.A. Neuwelt (Ed.), Implications of the Blood Brain Barrier and its Manipulation: Clinical Aspects, Vol. 2, Plenum Press, New York, 1989, pp. 195\u2013262.","DOI":"10.1007\/978-1-4615-7255-8_5"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0305-7372(89)90007-8","article-title":"The role of chemotherapy in the treatment of gliomas in adults","volume":"16","author":"Stewart","year":"1989","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB34","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ana.410190110","article-title":"Opening the blood\u2013brain and blood\u2013tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow","volume":"19","author":"Hiesiger","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000120809","article-title":"Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood\u2013brain barrier disruption","volume":"21","author":"Neuwelt","year":"1994","journal-title":"Pediatr. Neurosurg."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1227\/00006123-199505000-00012","article-title":"Gene expression from recombinant viral vectors in the central nervous system after blood\u2013brain barrier disruption","volume":"36","author":"Doran","year":"1995","journal-title":"Neurosurgery"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB37","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1227\/00006123-199404000-00048","article-title":"Delivery of virus-sized iron oxide particles to rodent CNS neurons","volume":"34","author":"Neuwelt","year":"1994","journal-title":"Neurosurgery"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB38","first-page":"166","article-title":"Non-AIDS primary CNS lymphoma: first example of a durable response in a primary brain tumor using enhanced chemotherapy delivery without cognitive loss and without radiotherapy","volume":"2","author":"Dahlborg","year":"1996","journal-title":"Cancer J. Sci. Am."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1006\/exnr.1996.0174","article-title":"Chemical induction of fenestrae in vessels of the blood\u2013brain barrier","volume":"142","author":"Kaya","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB40","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3171\/jns.1990.72.6.0912","article-title":"Selective opening of the blood\u2013tumour barrier by intracarotid infusion of leukotriene C4","volume":"72","author":"Black","year":"1990","journal-title":"J. Neurosurg."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3171\/jns.1992.77.3.0407","article-title":"Selective blood\u2013tumor barrier disruption by leukotrienes","volume":"77","author":"Chio","year":"1992","journal-title":"J. Neurosurg."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB42","first-page":"490","article-title":"Intracarotid infusion of leukotriene C4 increases blood tumor barrier permeability in experimental brain tumors","volume":"40","author":"King","year":"1989","journal-title":"Surg. Forum"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB43","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/jcbfm.1991.115","article-title":"Intracarotid infusion of leukotriene C4 selectively increases blood\u2013brain barrier permeability after focal ischemia in rats","volume":"11","author":"Baba","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/01616412.1992.11740093","article-title":"Increased opening of blood\u2013tumor barrier by leukotriene C4 is dependent on size of molecules","volume":"14","author":"Black","year":"1992","journal-title":"Neurol. Res."},{"issue":"5","key":"10.1016\/S0169-409X(98)00082-9_BIB45","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3171\/jns.1994.81.5.0745","article-title":"Enzymatic barrier protects brain capillaries from leukotriene C4","volume":"81","author":"Black","year":"1994","journal-title":"J. Neurosurg."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB46","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(94)90863-X","article-title":"Intracarotid infusion of bradykinin selectively increases blood\u2013tumor permeability in 9L and C6 brain tumors","volume":"659","author":"Nomura","year":"1994","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/S0169-409X(98)00082-9_BIB47","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/01616412.1994.11740209","article-title":"Intracarotid histamine infusion increases blood tumor permeability in RG2 glioma","volume":"16","author":"Inamura","year":"1994","journal-title":"Neurol. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB48","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1006\/exnr.1996.0175","article-title":"Controlled modulation of BBB permeability using the bradykinin agonist, RMP-7","volume":"142","author":"Bartus","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB49","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/exnr.1996.0156","article-title":"Unlocking the blood\u2013brain barrier: a role for RMP-7 in brain tumor therapy","volume":"141","author":"Elliot","year":"1996","journal-title":"Exp. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00006123-199607000-00025","article-title":"Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of the bradykinin analog, RMP-7","volume":"39","author":"Matsukado","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB51","doi-asserted-by":"crossref","first-page":"C161","DOI":"10.1152\/ajpcell.1982.243.3.C161","article-title":"Comparison of lipid-mediated blood\u2013brain barrier penetrability in neonates and adults","volume":"243","author":"Cornford","year":"1982","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB52","first-page":"H484","article-title":"An in situ perfusion technique to study cerebrovascular transport in the rat","volume":"247","author":"Takasato","year":"1984","journal-title":"Am. J. Physiol."},{"issue":"5","key":"10.1016\/S0169-409X(98)00082-9_BIB53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1528-1157.1992.tb02205.x","article-title":"Blood\u2013brain barrier penetration of felbamate","volume":"33","author":"Cornford","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB54","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/j.1471-4159.1985.tb08793.x","article-title":"Blood\u2013brain barrier transport of valproic acid","volume":"44","author":"Cornford","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB55","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1471-4159.1982.tb05350.x","article-title":"Transport of GABA at the blood\u2013CSF interface","volume":"38","author":"Loscher","year":"1982","journal-title":"J. Neurochem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB56","first-page":"797","article-title":"Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system","volume":"268","author":"Adkison","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB57","first-page":"899","article-title":"Distributional transport kinetics of zidovudine between plasma and brain extracellular fluid\/cerebrospinal fluid in the rabbit: investigation of the inhibitory effect of probenecid utilizing microdialysis","volume":"264","author":"Wong","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB58","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0140-6736(90)91988-M","article-title":"Zidovudine with probenecid","volume":"336","author":"Duckworth","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB59","first-page":"1227","article-title":"Microdialysis study of zidovudine (AST) transport in rat brain","volume":"267","author":"Dykstra","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB60","first-page":"138","article-title":"Melphalan penetration of the blood\u2013brain barrier via the neutral amino acid transporter in tumor-bearing brain","volume":"52","author":"Cornford","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB61","first-page":"2191","article-title":"Rapid high-affinity transport of a chemotherapeutic amino acid across the blood\u2013brain barrier","volume":"52","author":"Takada","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB62","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1015812725011","article-title":"Stereoselective transport of baclofen across the blood\u2013brain barrier in rats as determined by the unit impulse response methodology","volume":"8","author":"van Bree","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB63","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0920-1211(93)90078-L","article-title":"Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate","volume":"16","author":"Welty","year":"1993","journal-title":"Epilepsy Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB64","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1172\/JCI119832","article-title":"Vitamin C crosses the blood\u2013brain barrier in the oxidized form through the glucose transporters","volume":"100","author":"Agus","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB65","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1073\/pnas.95.6.2914","article-title":"Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1","volume":"95","author":"Veyhl","year":"1998","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB66","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0014-2999(96)00796-0","article-title":"Synthesis of glucose-chlorambucil derivatives and their recognition by the human GLUT1 glucose transporter","volume":"318","author":"Halmos","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-6215(96)00328-X","article-title":"Synthesis of O-methylsulfonyl derivatives of D-glucose as potential alkylating agents for targeted delivery to the brain. Evaluation of their interaction with the human erythrocyte GLUT1 hexose transporter","volume":"299","author":"Halmos","year":"1997","journal-title":"Carbohydr. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB68","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1172\/JCI111490","article-title":"Tracer kinetic model of blood\u2013brain barrier transport of protein-bound ligands. Empiric testing of the free hormone hypothesis","volume":"74","author":"Pardridge","year":"1984","journal-title":"J. Clin. Invest."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB69","unstructured":"E.M. Cornford, Blood\u2013brain barrier permeability to anticonvulsant drugs, in: R.H. Levy (Ed.), Metabolism of Antiepileptic Drugs, Raven Press, New York, 1984, pp. 129\u2013142."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB70","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/j.2326-1951.1987.tb02983.x","article-title":"The gatekeeper: how molecules are screened for admission to the brain","volume":"27","author":"Pardridge","year":"1987","journal-title":"The Sciences"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB71","first-page":"E264","article-title":"Absence of albumin receptor on brain capillaries in vivo or in vitro","volume":"249","author":"Pardridge","year":"1985","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB72","first-page":"E157","article-title":"Plasma protein-mediated transport of steroid and thyroid hormones","volume":"252","author":"Pardridge","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB73","unstructured":"W.M. Pardridge, Targeted Delivery of Hormones to Tissues, Handbook of Physiology (in press)."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB74","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/0006-2952(87)90545-4","article-title":"Effect of erythrocytes and plasma protein binding on the transport of progabide and SL 75102 through the rat blood\u2013brain barrier","volume":"36","author":"Hamberger","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB75","first-page":"333","article-title":"Uptake of catamphilic drugs into erythrocytes and muscular tissue correlates to membrane enrichment and to 45Ca displacement from phosphatidylserine monolayers","volume":"251","author":"Scheufler","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/00007691-198507030-00001","article-title":"Blood\u2013brain barrier transport of CI-912: single-passage equilibration of erythrocyte-borne drug","volume":"7","author":"Cornford","year":"1985","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB77","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1471-4159.1988.tb01055.x","article-title":"Effects of the binding of imipramine to erythrocytes and plasma proteins on its transport through the rat blood brain barrier","volume":"51","author":"Riant","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB78","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/edrv-2-1-103","article-title":"Transport of protein bound hormones into tissues in vivo","volume":"2","author":"Pardridge","year":"1981","journal-title":"Endocr. Rev."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB79","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1016\/0006-2952(88)90281-X","article-title":"Dialyzable serum cofactors(s) required for the protein-mediated transport of DL-propranolol into rat brain","volume":"37","author":"Lin","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB80","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1085\/jgp.51.5.335","article-title":"Characterization of biological membranes by equivalent pores","volume":"51","author":"Solomon","year":"1968","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB81","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4684-3279-4_4","article-title":"Membrane water channels and SH-groups","volume":"84","author":"Sha'afi","year":"1977","journal-title":"Adv. Exp. Biol. Med."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB82","unstructured":"W.M. Pardridge, Cerebral vascular permeability status in brain injury, in: Central Nervous System Trauma Status Report, 1983, chapt. 36, pp. 503\u2013512."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB83","unstructured":"C.W. Gottschalk, W.E. Lassiter, Transport of water: renal concentrating mechanism, in: G. Giebisch, D.C. Tosteson, H. Hussing (Eds.), Membrane Transport and Biology, Vol. IVA, Springer, New York, 1979, pp. 449\u2013471."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB84","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/0006-8993(78)90452-3","article-title":"Peripheral sympathetic regulation of brain water permeability","volume":"144","author":"Grubb","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB85","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0006-8993(78)90766-7","article-title":"Regulation of brain water permeability by centrally released vasopressin","volume":"143","author":"Raichle","year":"1978","journal-title":"Brain Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB86","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ana.410130107","article-title":"The effects of dexamethasone administration and withdrawal on water permeability across the blood\u2013brain barrier","volume":"13","author":"Reid","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB87","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0006-8993(70)90123-X","article-title":"Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard","volume":"24","author":"Oldendorf","year":"1970","journal-title":"Brain Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000114465","article-title":"Blood\u2013brain barrier permeability to lactate","volume":"6","author":"Oldendorf","year":"1972","journal-title":"Eur. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB89","unstructured":"W.H. Oldendorf, The blood\u2013brain barrier, in: H.E. Himwich (Ed.), Brain Metabolism and Clinical Disorders, 2nd ed., Spectrum Publications, New York, 1976, chapt. VII, pp. 163\u2013180."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB90","doi-asserted-by":"crossref","unstructured":"W.H. Oldendorf, The blood\u2013brain barrier, in: L.Z. Bito, H. Davson, J.D. Fenstermacher (Eds.), The Ocular and Cerebral Spinal Fluids, Exp. Eye Res. Suppl., 1977, pp. 177\u2013190.","DOI":"10.1016\/S0014-4835(77)80016-X"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB91","doi-asserted-by":"crossref","unstructured":"W.H. Oldendorf, Clearance of radiolabeled substances by brain after arterial injection using a diffusible internal standard, in: N. Marks, R. Rodnight (Eds.), Research Methods in Neurochemistry, Plenum Press, New York, 1981, chapt. 4, pp. 91\u2013112.","DOI":"10.1007\/978-1-4615-7757-7_4"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB92","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0006-8993(76)90024-X","article-title":"[3H]Tryptamine and [3H]-water as diffusible internal standards for measuring brain extraction of radiolabeled substances following carotid injection","volume":"113","author":"Oldendorf","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB93","doi-asserted-by":"crossref","unstructured":"E.M. Cornford, The carotid artery single injection technique, in: W.M. Pardridge (Ed.), Blood Brain Barrier: Methodology and Biology, Cambridge, 1998, chapt. 2, pp. 11\u201323.","DOI":"10.1017\/CBO9780511570216.002"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB94","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/jcbfm.1994.15","article-title":"The human brain GLUT1 glucose transporter: ultrastructural localization to the blood\u2013brain barrier endothelia","volume":"14","author":"Cornford","year":"1994","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB95","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jnr.490220413","article-title":"Glucose transporter localization in brain using light and electron immunocytochemistry","volume":"22","author":"Gerhart","year":"1989","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB96","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1073\/pnas.88.13.5779","article-title":"Blood\u2013brain barrier glucose transporter is asymmetrically distributed on brain capillary endothelial lumenal and ablumenal membranes: an electron microscopic immunogold study","volume":"88","author":"Farrell","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB97","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/jcbfm.1993.106","article-title":"An electron microscopic immunogold analysis of developmental upregulation of the blood brain barrier Glut1 glucose transporter","volume":"13","author":"Cornford","year":"1993","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB98","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1432-1033.1994.tb18550.x","article-title":"Facilitative glucose transporters","volume":"219","author":"Mueckler","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB99","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/00005072-199511000-00011","article-title":"High expression of the Glut1 glucose transporter in human brain hemangioblastoma endothelium","volume":"54","author":"Cornford","year":"1995","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/neu.1996.13.523","article-title":"Glut1 glucose transporter activity in human brain injury","volume":"13","author":"Cornford","year":"1996","journal-title":"J. Neurotrauma"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB101","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.410430615","article-title":"Dynamic FDG-PET analyses of hypometabolic zones in complex partial seizures: reduced blood\u2013brain barrier influx","volume":"43","author":"Cornford","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB102","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00004647-199801000-00003","article-title":"Interictal seizure resections show two configurations of endothelial Glut1 glucose transporter in the human blood brain barrier","volume":"18","author":"Cornford","year":"1998","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB103","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1152\/physrev.1983.63.4.1481","article-title":"Brain metabolism: a perspective from the blood\u2013brain barrier","volume":"63","author":"Pardridge","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB104","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/00005072-199607000-00008","article-title":"Chronic seizures increase glucose transporter abundance in rat brain","volume":"55","author":"Gronlund","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB105","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0092-8674(94)90361-1","article-title":"Molecular characterization of a membrane transporter for lactate pyruvate and other monocarboxylates: implications for the Cori cycle","volume":"76","author":"Garcia","year":"1994","journal-title":"Cell"},{"key":"10.1016\/S0169-409X(98)00082-9_BIB106","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1074\/jbc.270.4.1843","article-title":"cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1","volume":"270","author":"Garcia","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB107","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3290321","article-title":"Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past","volume":"329","author":"Price","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB108","first-page":"E207","article-title":"Expression of monocarboxylate transporter MCT1 by brain endothelium and glia in adult and suckling rats","volume":"273","author":"Gerhart","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB109","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.res.0000435856.47954.71","article-title":"Cellular and subcellular expression of the monocarboxylate transporter MCT1 in rat heart","volume":"80","author":"Johansson","year":"1997","journal-title":"Circ. Res."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB110","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1042\/bj3240447","article-title":"Cloning of the monocarboxylate transporter isoform MCT2 from rat testis provides evidence that expression in tissues is species specific and may involve post-transcriptional regulation","volume":"324","author":"Jackson","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB111","first-page":"63","article-title":"Immunocytochemical evaluation of blood\u2013brain barrier to endogenous albumin in adult, newborn and aged mice","volume":"32","author":"Vorbrodt","year":"1994","journal-title":"Folia Histochem. Cytobiol."},{"key":"10.1016\/S0169-409X(98)00082-9_BIB112","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00004647-199707000-00001","article-title":"Drug delivery to the brain","volume":"17","author":"Pardridge","year":"1997","journal-title":"J. Cereb. Blood Flow Metab."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X98000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X98000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T15:11:49Z","timestamp":1621005109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X98000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4]]},"references-count":112,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1999,4]]}},"alternative-id":["S0169409X98000829"],"URL":"https:\/\/doi.org\/10.1016\/s0169-409x(98)00082-9","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[1999,4]]}}}